Entity
  • aMoon Fund

    Created in 2016
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    131 9,366
  • Entity types

  • Location

    Ra'anana, Israel

    Ra'anana

    Israel

  • Employees

    Scale: 11-50

    Estimated: 52

  • Engaged corporates

    14
    1 12
  • Added in Motherbase

    3 years, 4 months ago
Description
  • Value proposition

    Accelerating Cure

    aMoon is a global HealthTech and Life Sciences investment fund based in Israel. As Israel’s largest HealthTech fund, with $1.1 billion AUM, we partner with outstanding entrepreneurs who harness groundbreaking science and technology to transform healthcare.

    Together with our portfolio companies, we work tirelessly to advance solutions that will help people live healthier, better lives.

    We harness our unique team of over 50 scientists, physicians and entrepreneurs and our global network of investors and industry leaders to build bridges between our portfolio companies and global tech, finance and medical research hubs to help entrepreneurs turn their vision into reality.

    Through our Velocity Fund we invest in companies pursuing disruptive, cutting-edge technologies as early as venture formation through Series A. Our Growth Fund invests in later-stage companies that are either generating revenue in growth rounds, pre-IPO rounds or in pivotal clinical trials.

    Healthcare, Biotechnology, Financial Services, Fund Management, Investment Management, Venture Capital, Biotechnology, Biopharmaceuticals, Digital Health, Medical Devices, Company Building, Early Stage Investments, Late Stage Investments, Israel, Life Sciences, and Health IT

  • aMoon - Accelerating Cure

    aMoon is a global HealthTech and Life Sciences investment fund based in Israel. We partner with outstanding entrepreneurs who harness groundbreaking science and technology to transform healthcare. Together with our portfolio companies, we work tirelessly to help founders bring revolutionary ideas to life quickly.

  • https://www.amoon.fund/
Corporate interactions BETA
Corporate TypeTweets Articles
Astellas Pharma
Astellas Pharma
Pharmaceutical
Astellas Pharma
Pharmaceutical
Other

3 Jul 2024


AbbVie
AbbVie
Pharmaceutical, Pharmaceutical Manufacturing
AbbVie
Pharmaceutical, Pharmaceutical Manufacturing
Other

3 Jul 2024


Novartis
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Other

3 Jul 2024


Dia & Co
Dia & Co
Semiconductors, Retail Apparel and Fashion
Dia & Co
Semiconductors, Retail Apparel and Fashion
Other

31 Mar 2024


Novo Nordisk
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Other

31 Mar 2024


Microsoft
Microsoft
IT services, Software Development
Microsoft
IT services, Software Development
Other

31 Mar 2024


Amazon
Amazon
IT services, Consumer Electronics, Software Development
Amazon
IT services, Consumer Electronics, Software Development
Other

17 Jan 2024


Roche
Roche
Pharmaceutical, Biotechnology, Biotechnology Research
Roche
Pharmaceutical, Biotechnology, Biotechnology Research
Other

31 Jan 2024


Amazon Web Services (AWS)
Amazon Web Services (AWS)
IT services, IT Services and IT Consulting
Amazon Web Services (AWS)
IT services, IT Services and IT Consulting
Other

4 Nov 2023


AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
Other

3 Jul 2024


Similar entities
Loading...
Loading...
Social network dynamics